Domagała-Kulawik J - Search Results

1

Immunotherapy of solid tumors: safety of treatment.

Domagała-Kulawik J, Leszek P, Owczarek W, Rawa T, Stelmachowska-Banaś M, Rutkowski P. Domagała-Kulawik J, et al. Pol Arch Intern Med. 2020 Sep 30;130(9):766-778. doi: 10.20452/pamw.15314. Epub 2020 Apr 24. Pol Arch Intern Med. 2020. PMID: 32329982 Free article. Review.

2

Immune checkpoint inhibitors in non-small cell lung cancer - towards daily practice.

Domagała-Kulawik J. Domagała-Kulawik J. Adv Respir Med. 2018;86(3). doi: 10.5603/ARM.2018.0022. Adv Respir Med. 2018. PMID: 29960281 Free article. Review.

3

Expression of Fas receptor on peripheral blood lymphocytes from patients with non-small cell lung cancer.

Hoser G, Wasilewska D, Domagała-Kulawik J. Hoser G, et al. Folia Histochem Cytobiol. 2004;42(4):249-52. Folia Histochem Cytobiol. 2004. PMID: 15704653 Free article.

4

Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.

Skirecki T, Hoser G, Domagała-Kulawik J, Kawiak J. Skirecki T, et al. Folia Histochem Cytobiol. 2009;47(1):111-5. doi: 10.2478/v10042-009-0018-y. Folia Histochem Cytobiol. 2009. PMID: 19419948 Free article.

5

Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer.

Domagała-Kulawik J. Domagała-Kulawik J. Pol Arch Intern Med. 2017 Apr 28;127(4):233-234. doi: 10.20452/pamw.4015. Epub 2017 Apr 28. Pol Arch Intern Med. 2017. PMID: 28452968 Free article. No abstract available.

6

The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients.

Domagala-Kulawik J. Domagala-Kulawik J. Expert Rev Respir Med. 2020 Mar;14(3):329-337. doi: 10.1080/17476348.2020.1708720. Epub 2019 Dec 25. Expert Rev Respir Med. 2020. PMID: 31865801 Review.

7

New Frontiers for Molecular Pathology.

Domagala-Kulawik J. Domagala-Kulawik J. Front Med (Lausanne). 2019 Dec 4;6:284. doi: 10.3389/fmed.2019.00284. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31867335 Free PMC article. Review.

8

Sex differences in clinico-pathologic characteristics and long-term survival among 17,192 surgically treated NSCLC patients: Nationwide population-based propensity score-matching study.

Trojnar A, Domagała-Kulawik J, Sienkiewicz-Ulita A, Zbytniewski M, Gryszko GM, Cackowski MM, Dziedzic M, Woźnica K, Orłowski TM, Dziedzic DA; Polish Lung Cancer Study Group (PLCSG). Trojnar A, et al. Among authors: domagala kulawik j. Surg Oncol. 2022 Dec;45:101873. doi: 10.1016/j.suronc.2022.101873. Epub 2022 Oct 23. Surg Oncol. 2022. PMID: 36335792

9

Reactivity of alveolar macrophages in lung cancer patients and healthy subjects: surface ICAM-1 after INF-gamma stimulation in vitro.

Hoser G, Grubek-Jaworska H, Droszcz P, Domagała-Kulawik J, Dabrowska M, Chazan R. Hoser G, et al. Folia Histochem Cytobiol. 2002;40(2):103-4. Folia Histochem Cytobiol. 2002. PMID: 12056599

10

Effect of IFN-gamma stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer.

Dabrowska M, Grubek-Jaworska H, Hoser G, Domagała-Kulawik J, Krenke R, Chazan R. Dabrowska M, et al. J Interferon Cytokine Res. 2006 Mar;26(3):190-5. doi: 10.1089/jir.2006.26.190. J Interferon Cytokine Res. 2006. PMID: 16542141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page